Xencor (XNCR) Total Non-Current Liabilities (2013 - 2026)
Xencor (XNCR) reported Total Non-Current Liabilities of $221.1 million for Q1 2026, down 6.77% quarter-over-quarter from $237.1 million in Q4 2025.
Xencor (XNCR) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 5 years of Total Non-Current Liabilities data on file, last reported at $221.1 million in Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $221.1 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $221.1 million (changed N/A YoY), and the FY2025 annual result was $237.1 million, down 11.5% from the prior year.
- Total Non-Current Liabilities retreated to $221.1 million in Q1 2026 per XNCR's latest filing, from $237.1 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $267.9 million in Q4 2024 and troughed at $221.1 million in Q1 2026.
- A 3-year average of $242.0 million and a median of $237.1 million in 2025 frame the typical range for Total Non-Current Liabilities.
- On a YoY basis, Total Non-Current Liabilities climbed as much as 11.5% in 2025 and fell as far as 11.5% in 2025.
- A 3-year view of Total Non-Current Liabilities shows it stood at $267.9 million in 2024, then decreased by 11.5% to $237.1 million in 2025, then fell by 6.77% to $221.1 million in 2026.
- Business Quant data shows XNCR's Total Non-Current Liabilities at $221.1 million in Q1 2026, $237.1 million in Q4 2025, and $267.9 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 11.03 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 95.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.87 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 64.76 Mn |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - | 221.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 221.06 Mn |
| Dec 31, 2025 | 237.12 Mn |
| Dec 31, 2024 | 267.93 Mn |
| Dec 31, 2014 | 8.53 Mn |
| Mar 31, 2013 | -15.10 Mn |